Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation

Beta secretase (BACE) inhibitors are promising therapeutic compounds currently in clinical phase II/III trials. Preclinical [(18)F]-florbetaben (FBB) amyloid PET imaging facilitates longitudinal monitoring of amyloidosis in Alzheimer's disease (AD) mouse models. Therefore, we applied this thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Brendel, Matthias, Jaworska, Anna, Overhoff, Felix, Blume, Tanja, Probst, Federico, Gildehaus, Franz-Josef, Bartenstein, Peter, Haass, Christian, Bohrmann, Bernd, Herms, Jochen, Willem, Michael, Rominger, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217065/
https://www.ncbi.nlm.nih.gov/pubmed/30429879
http://dx.doi.org/10.7150/thno.27868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217065/
https://www.ncbi.nlm.nih.gov/pubmed/30429879
http://dx.doi.org/10.7150/thno.27868

Ejemplares similares